Pharmabiz

Domain Therapeutics becomes Kainova Therapeutics and advances its clinical pipeline of GPCR-modulating therapies

Domain Therapeutics becomes Kainova Therapeutics and advances its clinical pipeline of GPCR-modulating therapies: Montreal, Canada Tuesday, January 13, 2026, 18:00 Hrs [IST] Kaino ...
Pharmabiz

Clover Biopharmaceuticals begins phase 2 trial for RSV + hMPV ± PIV3 respiratory combination vaccine candidates

Clover Biopharmaceuticals begins phase 2 trial for RSV + hMPV ± PIV3 respiratory combination vaccine candidates: Shanghai Tuesday, January 13, 2026, 17:00 Hrs [IST] Clover Biopha ...
Pharmabiz

Sentynl Therapeutics receives US FDA approval of Zycubo to treat paediatric patients with Menkes disease

Sentynl Therapeutics receives US FDA approval of Zycubo to treat paediatric patients with Menkes disease: Our Bureau, Bengaluru Tuesday, January 13, 2026, 15:45 Hrs [IST] Sentynl ...
Pharmabiz

Bionpharma gets US FDA nod for etravirine tablets developed in collaboration with STEERLife

Bionpharma gets US FDA nod for etravirine tablets developed in collaboration with STEERLife: Our Bureau, Bengaluru Tuesday, January 13, 2026, 16:15 Hrs [IST] Bionpharma Inc. has a ...
Pharmabiz

Boston Scientific enters agreement to acquire medical technology company, Valencia Technologies

Boston Scientific enters agreement to acquire medical technology company, Valencia Technologies: Marlborough, Massachusetts Tuesday, January 13, 2026, 16:00 Hrs [IST] Boston Scien ...
Pharmabiz

Great Place To Work report 1 in 5 employees struggle to adapt to workplace change in life sciences sector

Great Place To Work report 1 in 5 employees struggle to adapt to workplace change in life sciences sector: Our Bureau, Bengaluru Tuesday, January 13, 2026, 13:45 Hrs [IST] Great P ...
Pharmabiz

SciNeuro and Novartis ink licensing and collaboration agreement for next generation therapeutics to treat Alzheimer’s disease

SciNeuro and Novartis ink licensing and collaboration agreement for next generation therapeutics to treat Alzheimer’s disease: Rockville, Maryland Tuesday, January 13, 2026, 15: ...
Pharmabiz

AbbVie & RemeGen enter exclusive licensing agreement to develop novel bispecific antibody for advanced solid tumours

AbbVie & RemeGen enter exclusive licensing agreement to develop novel bispecific antibody for advanced solid tumours: North Chicago, Illinois Tuesday, January 13, 2026, 14:00 Hrs ...
Pharmabiz

Telangana DCA seizes spurious ‘Levipil 500’ falsely labelled as Sun Pharma product

Telangana DCA seizes spurious ‘Levipil 500’ falsely labelled as Sun Pharma product: Our Bureau, Chennai Tuesday, January 13, 2026, 15:30 Hrs [IST] The Drugs Control Administra ...
Pharmabiz

EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics

EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics: Stockholm, Sweden Tuesday, January 13, 2026, 13:00 Hrs [IST] EQT Life Sciences, formerly LSP, is one of Europe' ...
Pharmabiz

ShardaCare Healthcity with GIFT to host thalassaemia awareness with a free HLA testing camp

ShardaCare Healthcity with GIFT to host thalassaemia awareness with a free HLA testing camp: Our Bureau, Bengaluru Tuesday, January 13, 2026, 12:45 Hrs [IST] ShardaCare Healthcity ...
Pharmabiz

Biocon arm gets US FDA nod for generic everolimus tablets

Biocon’s arm Biocon Pharma has received approval from the US health regulator for its generic version of everolimus tablets for oral suspension used in the treatment of tuberous sclerosis complex, a ...